Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Newlink Genetics Cor (NLNK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 71,197
  • Shares Outstanding, K 37,276
  • Annual Sales, $ 12,470 K
  • Annual Income, $ -53,600 K
  • 60-Month Beta 1.85
  • Price/Sales 6.19
  • Price/Cash Flow N/A
  • Price/Book 0.67

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.30
  • Number of Estimates 3
  • High Estimate -0.29
  • Low Estimate -0.32
  • Prior Year -0.49
  • Growth Rate Est. (year over year) +38.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.58 +20.89%
on 02/28/19
2.27 -15.86%
on 03/19/19
+0.26 (+16.11%)
since 02/22/19
3-Month
1.28 +49.22%
on 01/24/19
2.27 -15.86%
on 03/19/19
+0.40 (+26.49%)
since 12/21/18
52-Week
1.28 +49.22%
on 01/24/19
7.77 -75.42%
on 03/29/18
-5.47 (-74.12%)
since 03/22/18

Most Recent Stories

More News
NewLink Genetics Announces Clinical Trial Abstract Presentation at AACR Annual Meeting

NewLink Genetics Corporation (NASDAQ:NLNK) today announced that a late-breaking abstract reporting results from a Phase 2 study of NLG207, a nanoparticle formulation of the topoisomerase 1 inhibitor, camptothecin,...

NLNK : 1.91 (-7.73%)
NewLink Genetics Reports Fourth Quarter, Year-End 2018 Financial Results and Provides Update for Clinical Programs

NewLink Genetics Corporation (NASDAQ:NLNK) today reported consolidated financial results for the fourth quarter and year ended 2018, as well as progress in its clinical development programs. The Company...

NLNK : 1.91 (-7.73%)
NewLink Genetics to Host Its Fourth Quarter and Full Year 2018 Financial Results Conference Call on February 27, 2019

NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will release its fourth quarter and full year 2018 financial results on Wednesday, February 27, 2019. The company has scheduled a conference...

NLNK : 1.91 (-7.73%)
Factors of Influence in 2019, Key Indicators and Opportunity within Marathon Oil, Accuray, United Natural Foods, Systemax, Amgen, and NewLink Genetics -- New Research Emphasizes Economic Growth

In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Marathon Oil Corporation...

SYX : 21.30 (-1.11%)
ARAY : 4.71 (-1.88%)
MRO : 16.68 (-5.71%)
UNFI : 13.03 (-3.98%)
AMGN : 186.70 (-2.70%)
NLNK : 1.91 (-7.73%)
NewLink Genetics to Participate in the Immuno-Oncology 360° Conference

NewLink Genetics Corporation (NASDAQ:NLNK) announced today that the Company's Chairman, CEO and Chief Scientific Officer, Charles J. Link, Jr, MD, will participate in the Immuno-Oncology 360 Conference...

NLNK : 1.91 (-7.73%)
Corelogic Inc Has Returned 24.8% Since SmarTrend Recommendation (CLGX)

SmarTrend identified a Downtrend for Corelogic Inc (NYSE:CLGX) on July 26th, 2018 at $51.30. In approximately 4 months, Corelogic Inc has returned 24.83% as of today's recent price of $38.56.

CTT : 9.51 (-2.36%)
EPAY : 48.33 (-4.88%)
EXAS : 89.00 (-3.28%)
WYNN : 116.91 (-3.49%)
HMSY : 30.88 (-6.11%)
GLT : 13.31 (-4.79%)
MHK : 124.86 (-2.56%)
BBW : 5.55 (+0.18%)
CDW : 95.87 (-2.75%)
COUP : 90.40 (-8.95%)
QTWO : 68.44 (-3.32%)
DENN : 17.84 (+0.11%)
MYL : 28.69 (-1.91%)
DFRG : 6.50 (-0.46%)
GCAP : 6.40 (-2.88%)
FEYE : 16.67 (-4.03%)
MXIM : 54.21 (-1.90%)
POL : 28.60 (-6.14%)
AN : 33.57 (-3.20%)
TWO : 13.80 (-0.93%)
HUBG : 39.74 (-3.57%)
AR : 8.39 (-4.00%)
RE : 214.99 (-0.23%)
NNBR : 7.65 (-4.02%)
ARE : 141.72 (-0.51%)
CVI : 40.68 (-2.87%)
CERS : 6.16 (-4.64%)
NDAQ : 83.89 (-0.55%)
ELLI : 98.55 (-0.14%)
BLDR : 12.55 (-4.85%)
EGRX : 47.15 (-6.85%)
RGLD : 92.06 (-0.20%)
PRGO : 47.25 (-2.74%)
PENN : 20.19 (-4.04%)
NTAP : 66.84 (-3.84%)
IBM : 139.45 (-1.41%)
NTRI : 42.89 (-0.05%)
BANR : 51.97 (-3.04%)
CWT : 53.73 (-1.56%)
STAA : 37.67 (-4.39%)
ATHN : 134.99 (+0.01%)
CL : 66.00 (+0.26%)
TFSL : 15.96 (-2.27%)
UFPI : 29.22 (-5.28%)
SDRL : 9.21 (-9.26%)
GOV : 6.87 (-5.50%)
HQY : 73.78 (-10.82%)
IPGP : 144.77 (-5.43%)
MINI : 33.08 (-4.59%)
CMTL : 21.17 (-4.68%)
CHD : 67.10 (+0.49%)
GPI : 60.34 (-4.24%)
HRL : 43.59 (+1.11%)
RARE : 64.65 (-6.36%)
MLI : 30.71 (-4.54%)
GPS : 24.52 (-2.39%)
CHS : 4.23 (-5.37%)
RYAM : 12.67 (-6.98%)
PBI : 6.34 (-6.21%)
NUVA : 56.00 (-1.20%)
IMDZ : 5.85 (+0.17%)
CAMP : 12.24 (-4.00%)
NOC : 268.36 (-1.51%)
AEL : 26.77 (-6.30%)
EBIX : 47.92 (-5.59%)
DISCA : 26.67 (-0.04%)
GPOR : 7.63 (-3.42%)
BGS : 24.64 (-0.44%)
TECH : 192.34 (-4.04%)
PCH : 36.36 (-2.83%)
NOV : 26.63 (-4.55%)
TECD : 98.45 (-5.97%)
DISCK : 25.45 (+0.04%)
DECK : 140.51 (-3.90%)
NOW : 241.21 (-3.88%)
MGLN : 64.63 (-2.30%)
IEX : 147.93 (-2.45%)
PTC : 93.12 (-1.94%)
AVT : 42.12 (-4.45%)
RGS : 18.26 (-2.56%)
BSFT : 54.95 (+0.09%)
FOSL : 13.88 (-4.74%)
WAL : 39.07 (-5.40%)
IVR : 16.09 (-0.80%)
ENR : 45.09 (-2.28%)
ISBC : 11.45 (-3.13%)
SHOO : 32.17 (-3.36%)
HDP : 14.68 (+1.80%)
AWK : 106.78 (+0.53%)
OMED : 0.88 (-2.02%)
LADR : 16.73 (-1.36%)
BIG : 35.05 (-0.57%)
WY : 25.76 (-1.64%)
JBLU : 15.93 (-2.27%)
GNMK : 7.30 (-2.67%)
FORM : 15.77 (-3.67%)
PFSI : 21.11 (-3.25%)
NEWM : 11.47 (-3.45%)
KFRC : 34.20 (-4.92%)
HOLX : 46.85 (-1.82%)
TMK : 80.31 (-2.50%)
AXTA : 24.88 (-3.72%)
PGEM : 21.65 (unch)
CLH : 70.31 (-1.65%)
CLI : 21.87 (-2.28%)
NRG : 42.49 (-2.03%)
CLGX : 35.94 (-1.07%)
SFLY : 39.32 (-3.46%)
ICUI : 229.27 (-2.97%)
CARA : 18.30 (-6.82%)
WTR : 37.12 (+0.65%)
NTGR : 33.71 (-3.91%)
OLED : 154.31 (-4.52%)
VNDA : 17.59 (-4.61%)
HIBB : 21.70 (+20.29%)
FFBC : 23.02 (-4.92%)
DLTR : 101.43 (+0.02%)
EQT : 19.51 (-3.70%)
OMER : 16.89 (-4.68%)
KTOS : 15.63 (-3.16%)
SRCL : 50.49 (+0.68%)
GES : 18.37 (-4.87%)
KMX : 61.63 (-1.09%)
PLAB : 9.09 (-3.71%)
NCS : 6.05 (-6.20%)
MAR : 124.50 (-0.45%)
MRVL : 19.71 (-5.19%)
UAL : 79.63 (-1.69%)
CNK : 39.84 (-0.10%)
NATH : 69.11 (-2.41%)
TPH : 12.38 (-0.64%)
OCUL : 3.94 (-5.29%)
SKYW : 51.60 (-2.66%)
HIVE : 4.42 (-4.12%)
GAIA : 9.24 (-1.60%)
ESRX : 92.33 (-3.62%)
PHM : 26.58 (+1.06%)
EBS : 48.33 (-1.37%)
CACI : 180.27 (-2.96%)
SAVE : 53.05 (-1.74%)
EZPW : 9.11 (-4.11%)
TPX : 55.17 (-4.19%)
KLAC : 120.53 (-2.64%)
ULTA : 330.52 (-1.38%)
WWE : 86.71 (-5.87%)
ESV : 4.23 (-4.30%)
LTRPA : 13.93 (-4.33%)
DAL : 49.76 (-1.07%)
BMY : 48.16 (-1.55%)
ECL : 173.38 (-1.39%)
CHRW : 84.68 (-2.98%)
WWW : 34.62 (-3.73%)
ETH : 18.55 (-3.08%)
IART : 55.29 (-3.56%)
LE : 15.83 (-1.80%)
LH : 154.32 (-1.27%)
HZO : 18.07 (-3.93%)
MTD : 702.07 (-3.79%)
OSTK : 18.41 (-5.59%)
LDOS : 62.99 (-1.19%)
SAGE : 156.72 (-0.80%)
CIEN : 37.06 (-3.82%)
MTW : 16.30 (-4.73%)
AMC : 15.06 (-2.33%)
NDLS : 6.61 (-2.22%)
EFII : 26.00 (-5.90%)
SIVB : 212.19 (-7.06%)
MU : 41.62 (-5.39%)
DSW : 20.32 (-3.61%)
VRNT : 50.95 (-3.76%)
OII : 15.56 (-7.49%)
SAFM : 127.26 (-0.24%)
DATA : 127.85 (-6.43%)
TLYS : 11.00 (-5.42%)
TREE : 330.64 (-3.16%)
TRUP : 29.72 (-6.36%)
AMCX : 56.32 (-2.00%)
EXPD : 74.12 (-2.33%)
SUPN : 35.66 (-5.64%)
NBIX : 85.11 (-5.25%)
SAIC : 70.99 (-2.50%)
CBM : 38.19 (-2.73%)
BURL : 145.99 (-2.03%)
AMED : 122.60 (-2.92%)
EXPR : 3.93 (-4.61%)
SBH : 17.59 (-0.51%)
ATSG : 21.16 (-3.11%)
PLT : 47.43 (-7.65%)
QDEL : 63.72 (-5.93%)
NLNK : 1.91 (-7.73%)
STMP : 82.71 (-3.99%)
IPCC : 142.80 (+0.32%)
BMTC : 34.51 (-5.37%)
STML : 12.37 (-6.71%)
EGL : 29.10 (+0.24%)
LUV : 49.32 (-2.80%)
CCL : 56.42 (-1.47%)
INOV : 12.26 (-2.62%)
COTY : 11.22 (-0.53%)
MGM : 26.09 (-3.01%)
AKBA : 8.39 (-3.56%)
LGIH : 58.19 (+3.67%)
CDNS : 61.76 (-2.09%)
CRZO : 12.19 (-7.72%)
TEN : 22.55 (-7.96%)
HAIN : 23.29 (+0.22%)
NewLink Genetics Announces Merck Has Begun Rolling Submission of Licensure Application for Ebola vaccine V920 (rVSVDG-ZEBOV-GP) to U.S. Food and Drug Administration

In 2014 the Company entered into a license agreement with Merck to develop, manufacture and commercialize NewLink Genetics' Ebola vaccine candidate

MRK : 82.29 (-0.80%)
NLNK : 1.91 (-7.73%)
NewLink Genetics Announces Final Results from Phase 2 Studies of Indoximod in Advanced Melanoma and Metastatic Pancreatic Cancer to be Presented at ASCO 2018

NewLink Genetics Corporation (NASDAQ:NLNK) today announced that abstracts from two Phase 2 studies of indoximod, used in combination with other agents, are now available on the website of the 2018 American...

NLNK : 1.91 (-7.73%)
Stock Performance Review on Biotech Industry -- Neptune Technologies & Bioressources, NewLink Genetics, OHR Pharma, and Omeros

If you want a free Stock Review on NEPT, NLNK, OHRP, and OMER sign up now at www.wallstequities.com/registration. On Monday, the NASDAQ Composite ended the day at 7,265.21, up 0.77%; the Dow Jones Industrial...

OHRP : 2.24 (-3.86%)
OMER : 16.89 (-4.68%)
NEPT : 2.98 (-7.17%)
NLNK : 1.91 (-7.73%)
NewLink Genetics Reports First Quarter 2018 Financial Results

NewLink Genetics Corporation (NASDAQ:NLNK) today reported consolidated financial results for the first quarter 2018 and reviewed recent highlights and upcoming milestones.

NLNK : 1.91 (-7.73%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators mostly agree with the trend.

See More Share

Trade NLNK with:

Business Summary

NewLink Genetics Corporation is a biopharmaceutical company which focuses on discovering, developing and commercializing immunotherapeutic products for cancer treatment. Its portfolio also includes biologic and small-molecule immunotherapy products used for the treatment of oncology indications. NewLink...

See More

Key Turning Points

2nd Resistance Point 2.16
1st Resistance Point 2.03
Last Price 1.91
1st Support Level 1.84
2nd Support Level 1.78

See More

52-Week High 7.77
Fibonacci 61.8% 5.29
Fibonacci 50% 4.53
Fibonacci 38.2% 3.76
Last Price 1.91
52-Week Low 1.28

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar